WO1999039006A3 - Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions - Google Patents
Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions Download PDFInfo
- Publication number
- WO1999039006A3 WO1999039006A3 PCT/US1999/001964 US9901964W WO9939006A3 WO 1999039006 A3 WO1999039006 A3 WO 1999039006A3 US 9901964 W US9901964 W US 9901964W WO 9939006 A3 WO9939006 A3 WO 9939006A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- human
- polypeptide sequences
- physiological
- medical conditions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1072—Differential gene expression library synthesis, e.g. subtracted libraries, differential screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1079—Screening libraries by altering the phenotype or phenotypic trait of the host
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU24841/99A AU769931B2 (en) | 1998-01-30 | 1999-01-29 | Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
JP2000529463A JP2002501761A (en) | 1998-01-30 | 1999-01-29 | Methods for identifying polynucleotide and polypeptide sequences for physiological and medical conditions |
CA002318772A CA2318772A1 (en) | 1998-01-30 | 1999-01-29 | Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
EP99904442A EP1051519A2 (en) | 1998-01-30 | 1999-01-29 | Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
PCT/US1999/020209 WO2000012764A1 (en) | 1998-09-02 | 1999-09-01 | Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
AU58058/99A AU5805899A (en) | 1998-09-02 | 1999-09-01 | Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7326398P | 1998-01-30 | 1998-01-30 | |
US60/073,263 | 1998-01-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999039006A2 WO1999039006A2 (en) | 1999-08-05 |
WO1999039006A3 true WO1999039006A3 (en) | 1999-11-04 |
Family
ID=22112723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/001964 WO1999039006A2 (en) | 1998-01-30 | 1999-01-29 | Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1051519A2 (en) |
JP (1) | JP2002501761A (en) |
CA (1) | CA2318772A1 (en) |
WO (1) | WO1999039006A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6280953B1 (en) * | 1998-01-30 | 2001-08-28 | Evolutionary Genomics, L.L.C. | Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
US6866996B1 (en) | 1998-01-30 | 2005-03-15 | Evolutionary Genomics, Llc | Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
US7247425B2 (en) | 1998-01-30 | 2007-07-24 | Evolutionary Genomics, Llc | Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
WO2005024066A1 (en) * | 2003-06-30 | 2005-03-17 | Evolutionary Genomics Llc | Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
-
1999
- 1999-01-29 EP EP99904442A patent/EP1051519A2/en not_active Ceased
- 1999-01-29 WO PCT/US1999/001964 patent/WO1999039006A2/en active IP Right Grant
- 1999-01-29 JP JP2000529463A patent/JP2002501761A/en active Pending
- 1999-01-29 CA CA002318772A patent/CA2318772A1/en not_active Abandoned
Non-Patent Citations (6)
Title |
---|
BURGER H. ET AL.,: "Molecular evolution of interleukin-3", J. MOL. EVOL., vol. 39, no. 3, - September 1994 (1994-09-01), pages 255 - 267, XP002114680 * |
HERBERT G. & EASTEAL S.: "Relative rates of nuclear DNA evolution in human and old world monkey lineages", MOL. BIOL. EVOL., vol. 13, no. 7, - September 1996 (1996-09-01), pages 1054 - 1057, XP002114698 * |
JAEGER E. ET AL.,: "Structure, diversity, and evolution of the T-cell receptor VB gene repertoire in primates", IMMUNOGENETICS, vol. 40, no. 3, - 1994, pages 184 - 191, XP002114681 * |
LEE M.E. ET AL.,: "Molecular cloning and expression of rhesus macaque and sooty mangabey interleukin 16: biologic activity and effect on simian immunodeficiency virus infection and/or replication", AIDS RESEARCH AND HUMAN RETROVIRUSES, vol. 14, no. 15, - 15 October 1998 (1998-10-15), pages 1323 - 1328, XP002114679 * |
LYN D. ET AL.,: "Conservation of sequences between human and gorilla lineages: ADP-ribosyltransferase(NAD+) pseudogene 1 and neighboring retroposons", GENE, vol. 155, - 1995, pages 241 - 245, XP002114678 * |
MESSIER W. & STEWART C.-B.: "Episodic adaptive evolution of primate lysozymes", NATURE, vol. 385, - 9 January 1997 (1997-01-09), pages 151 - 154, XP002114682 * |
Also Published As
Publication number | Publication date |
---|---|
CA2318772A1 (en) | 1999-08-05 |
EP1051519A2 (en) | 2000-11-15 |
WO1999039006A2 (en) | 1999-08-05 |
JP2002501761A (en) | 2002-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002040634A3 (en) | Expression miniarrays and uses thereof | |
WO2008030273A3 (en) | Compositions and methods for diagnosis and treatment of type 2 diabetes | |
CA2411589A1 (en) | Method and apparatus for displaying information obtained by electrical impedance tomography data | |
CA2274596A1 (en) | Compositions and methods for enhancing intestinal function | |
EP1510403A3 (en) | System, method, and receiver module for alerting users of warning signals | |
EP2006298A3 (en) | Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof | |
WO2003095618A3 (en) | Identification of dysregulated genes in patients with multiple sclerosis | |
WO2000018954A3 (en) | Use of pex in the treatment of metabolic bone diseases | |
AU8881201A (en) | Tnf receptor-like molecules and uses thereof | |
ES2166822T3 (en) | CROHN DISEASE SELECTION PROCEDURES USING TNF MICROSATELITES ALELOS. | |
EP2298360A3 (en) | Methods and immune modulatory nucleic acid compositions for preventing and treating disease | |
WO2001096603A3 (en) | Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions | |
EP1163515A4 (en) | Therapeutic and diagnostic tools for impaired glucose tolerance conditions | |
WO2000034511A3 (en) | Aβ-PEPTIDE SCREENING ASSAY | |
WO2003088823A3 (en) | Novel macrocyclic activatible magnetic resonance imaging contrast agents | |
WO1999066075A3 (en) | Diagnostic method based on quantification of extramitochondrial dna | |
WO1999039006A3 (en) | Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions | |
CA2534643A1 (en) | Methods for screening and identifying compounds | |
WO1999058639A3 (en) | Structural proteins of fish pancreatic disease virus and uses thereof | |
MXPA03000979A (en) | C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF. | |
WO2003086563A3 (en) | Diabetes imaging probes | |
WO2004087752A3 (en) | Spinster-like protein genes, expression products, non-human animal model: uses in human metabolic disorders | |
WO2003038130A3 (en) | Therapeutics and diagnostics for disorders of erythropoiesis | |
GB9905218D0 (en) | Neurodegenerative disorder related gene | |
BR0014167A (en) | Proteìna iren, its preparation and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
ENP | Entry into the national phase |
Ref document number: 2318772 Country of ref document: CA Ref country code: CA Ref document number: 2318772 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 24841/99 Country of ref document: AU |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 529463 Kind code of ref document: A Format of ref document f/p: F |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1999904442 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999904442 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 24841/99 Country of ref document: AU |